알츠하이머병에서 혈관위험인자, 내측두엽위축과백질병변이 인지기능에 미치는 영향
Impact of Vascular Risk Factors, Axial Medial Temporal Atrophy,White Matter Hyperintensity on Cognitive Outcome in Alzheimer’s Diseases
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: There is epidemiologic evidence to support vascular disease as a possible cause of Alzheimer’s dementia (AD). The primary aim of this study was to determine the prevalence of vascular risk factors (vRFs) with respect to various clinical measures, such as axial-rated medial temporal lobe atrophy (MTA), ischemic white-matter changes, and cognition. The secondary aim was to determine the most significant clinical measure associated with cognitive outcome. Methods: The study subjects comprised 198 probable AD and 38 subjective memory impairment–no cognitive impairment controls (SMI-NCI), for whom medical data including history vRF-related blood tests, clinical dementia evaluation, cognitive assessment, and brain MRI, were available. The grading of white-matter hyperintensities (WMHs)was achieved using Fazekas’ method. MTA was graded by two neurologists independently based on axial T1-weighted MRI images. The prevalence of risk factors for Koreans aged ≥65 years was reviewed for comparison. Results: All vRFs except smoking were more severe in the AD group than in both the SMI-NCI group and Koreans aged ≥65 years, but the high prevalence of vRFs had no impact on WMH lesions, axial MTA, or cognitive outcome. Both white-matter changes and MTA were significantly worse in AD than in SMI-NCI (p<0.001). The degree of MTA was negatively correlated with WMH grade (p<0.001), but the severity of clinical dementia was correlated only with increased axial MTA in AD (Instrumental Activities of Daily Living and Clinical Dementia Rating scores, p<0.001;Clinical Dementia Rating-Sum of Boxes score, p<0.005). Conclusions: WMHs and axial MTA were significantly more severe in the AD group than in the SMI-NCI subjects. The findings of this study indicate that worsening of cognitive dysfunction in AD appears to be driven by MTA, which is evident even in axial MTA visual grading, irrespective of WMH severity and the presence of vRFs.
Abstract
Background: There is epidemiologic evidence to support vascular disease as a possible cause of Alzheimer’s dementia (AD). The primary aim of this study was to determine the prevalence of vascular risk factors (vRFs) with respect to various clinical measures, such as axial-rated medial temporal lobe atrophy (MTA), ischemic white-matter changes, and cognition. The secondary aim was to determine the most significant clinical measure associated with cognitive outcome. Methods: The study subjects comprised 198 probable AD and 38 subjective memory impairment–no cognitive impairment controls (SMI-NCI), for whom medical data including history vRF-related blood tests, clinical dementia evaluation, cognitive assessment, and brain MRI, were available. The grading of white-matter hyperintensities (WMHs)was achieved using Fazekas’ method. MTA was graded by two neurologists independently based on axial T1-weighted MRI images. The prevalence of risk factors for Koreans aged ≥65 years was reviewed for comparison. Results: All vRFs except smoking were more severe in the AD group than in both the SMI-NCI group and Koreans aged ≥65 years, but the high prevalence of vRFs had no impact on WMH lesions, axial MTA, or cognitive outcome. Both white-matter changes and MTA were significantly worse in AD than in SMI-NCI (p<0.001). The degree of MTA was negatively correlated with WMH grade (p<0.001), but the severity of clinical dementia was correlated only with increased axial MTA in AD (Instrumental Activities of Daily Living and Clinical Dementia Rating scores, p<0.001;Clinical Dementia Rating-Sum of Boxes score, p<0.005). Conclusions: WMHs and axial MTA were significantly more severe in the AD group than in the SMI-NCI subjects. The findings of this study indicate that worsening of cognitive dysfunction in AD appears to be driven by MTA, which is evident even in axial MTA visual grading, irrespective of WMH severity and the presence of vRFs.
참고문헌 (31)
- Kivipelto M, "Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study", BMJ, 322, pp.1447~1451 (2001)
- Wippold FJ, "Neuropathology for the neuroradiologist : plaques and tangles", AJNR Am J Neuroradiol, 29, pp.18~22 (2008)
- Snowdon DA, "Brain infarction and the clinical expression of Alzheimer disease. The Nun study", JAMA, 277, pp.813~817 (1997)
- Garde E, "Decline in intelligence is associated with progression in white matter hyperintensity volume", J Neurol Neurosurg Psychiatry, 76, pp.1289~1291 (2005)
- Pantoni L, "The relation between white-matter lesions and cognition", Curr Opin Neurol, 20, pp.390~397 (2007)
- Bolandzadeh N, "The association between cognitive function and white matter lesion location in older adults : a systematic review", BMC Neurol, 12, pp.126~ (2012)
- Appel J, "Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors", AJNR Am J Neuroradiol, 30, pp.1870~1876 (2009)
- Staekenborg SS, "Progression of mild cognitive impairment to dementia : contribution of cerebrovascular disease compared with medial temporal lobe atrophy", Stroke, 40, pp.1269~1274 (2009)
- Shim YS, "Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with alzheimer’s disease", Eur Neurol, 66, pp.75~82 (2011)
- Jang JW, "Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease", Eur Neurol, 69, pp.229~235 (2013)
- McKhann G, "Clinical diagnosis of Alzheimer’s disease : report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease", Neurology, 34, pp.939~944 (1984)
- Kang Y, "Seoul Neuropsychological Screening Battery" (2003), Human Brain Research & Consulting Co
- 김건하, "내측 측두엽 위축의 T1-축영상 시각 척도제안: Schelten의 관영상 시각척도와 비교연구", Dementia and Neurocognitive Disorders(대한치매학회지), 8(1), pp.37~44 (2009), 대한치매학회
- Fazekas F, "MR signal abnormalities at 1.5T Alzheimer’s dementia and normal aging", AJR Am J Roentgenol, 149, pp.351~356 (1987)
- van der Flier WM, "Small vessel disease and general cognitive function in nondisabled elderly : the LADIS study", Stroke, 36, pp.2116~2120 (2005)
- 박태환, "한국인에서 허혈성 뇌졸중 위험 인자의 유병률에 대한 체계적 문헌 고찰", 대한신경과학회지, 27(1), pp.19~27 (2009), 대한신경과학회
- Gorelick PB, "Risk factors for vascular dementia and Alzheimer disease", Stroke, 35, pp.2620~2622 (2004)
- Akomolafe A, "Diabetes mellitus and risk of developing Alzheimer disease ; results from the Framingham Study", Arch Neurol, 63, pp.1551~1555 (2006)
- Miyasaka Y, "Risk of dementia in stroke-free patients diagnosed with atrial fibrillation : data from a community-based cohort", Eur Heart J, 28, pp.1962~1967 (2007)
- Birns J, "Hypertension-related cognitive decline: is the time right for intervention studies?", Minerva Cardiolangiol, 57, pp.813~830 (2009)
- Neumann KF, "Insulin resistance and Alzheimer’s disease : molecular link & clinical implications", Curr Alzheimer Res, 5, pp.438~447 (2008)
- Casserly I, "Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins", Lancet, 363, pp.1139~1146 (2004)
- Firbank MJ, "Meidal temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survive", Neurobiol Aging, 28, pp.1664~1669 (2007)
- van der Flier WM, "Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people : the LADIS study", J Neurol Neurosurg Psychiatry, 76, pp.1497~1500 (2005)
- Visser PJ, "Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment", J Neurol Neurosurg Psychiatry, 72, pp.491~497 (2002)
- Burton EJ, "Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment : a prospective study with pathological verification of diagnosis", Brain, 132, pp.195~203 (2009)
- Villain N, "Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer’s disease", J Neurosci, 28, pp.6174~6181 (2008)
- Silverberg GD, "Alzheimer’s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis", Lancet Neurol, 2, pp.506~511 (2003)
- Bronge L, "White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype", Dement Geriatr Cogn Disord, 10, pp.89~96 (1999)
- 손의주, "알쯔하이머병 환자에서 아포지단백E 유전자형과 혈관성 위험인자와의 관계", 대한신경과학회지, 21(1), pp.41~45 (2003), 대한신경과학회
- Swanwick G, "Is female gender a risk factor for Alzheimer’s disease?", Int Psychogeriatr, 11, pp.219~222 (1999)